Topics covered in this report – which features the exclusive insights of government ministers, the heads of local pharma champions as well as multinational affiliate leaders – include the potential impact of Algeria’s sweeping new healthcare law, the establishment of the country’s first National Cancer Plan, global companies’ scramble to localise manufacturing operations, an investment wave from the Middle East, and Algeria’s ramped-up export capabilities.
Algeria / Pharma & Healthcare: 5 Things to Know
With a healthcare system marked by both progress and difficulties due to the country’s economic overreliance on the oil and gas sector and its recent political instability, Algeria, is the…
